CN101288650B - 一种依达拉奉的冻干制剂及其制备工艺 - Google Patents
一种依达拉奉的冻干制剂及其制备工艺 Download PDFInfo
- Publication number
- CN101288650B CN101288650B CN 200810123767 CN200810123767A CN101288650B CN 101288650 B CN101288650 B CN 101288650B CN 200810123767 CN200810123767 CN 200810123767 CN 200810123767 A CN200810123767 A CN 200810123767A CN 101288650 B CN101288650 B CN 101288650B
- Authority
- CN
- China
- Prior art keywords
- edaravone
- preparation
- water
- lyophilized formulations
- tert
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200810123767 CN101288650B (zh) | 2008-06-04 | 2008-06-04 | 一种依达拉奉的冻干制剂及其制备工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200810123767 CN101288650B (zh) | 2008-06-04 | 2008-06-04 | 一种依达拉奉的冻干制剂及其制备工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101288650A CN101288650A (zh) | 2008-10-22 |
CN101288650B true CN101288650B (zh) | 2010-12-15 |
Family
ID=40033211
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200810123767 Active CN101288650B (zh) | 2008-06-04 | 2008-06-04 | 一种依达拉奉的冻干制剂及其制备工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101288650B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102159229A (zh) | 2008-11-20 | 2011-08-17 | 帝国制药美国公司 | 吡唑啉酮衍生物制剂 |
CN101805292B (zh) * | 2010-04-27 | 2012-01-25 | 江苏先声药物研究有限公司 | 吡唑啉类化合物、用途及其制备方法 |
CN101933899A (zh) * | 2010-08-26 | 2011-01-05 | 南京先声东元制药有限公司 | 一种依达拉奉注射液及其制备方法 |
CN105646530B (zh) * | 2014-12-03 | 2020-05-12 | 南京先声东元制药有限公司 | 苯基吡唑类化合物及其制备方法与用途 |
-
2008
- 2008-06-04 CN CN 200810123767 patent/CN101288650B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN101288650A (zh) | 2008-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101288650B (zh) | 一种依达拉奉的冻干制剂及其制备工艺 | |
US11771773B2 (en) | Pharmaceutical preparation containing polyethylene gylcol loxenatide and preparation method thereof | |
CN102091028A (zh) | 一种依达拉奉注射液及其制备方法 | |
EP2620153B1 (en) | 5 alpha-androstane (alkyl)-3 beta,5,6 beta-triol injection and preparation method therefor | |
CN1241565C (zh) | 依达拉奉药物组合物及制备 | |
CN105213330B (zh) | 一种帕瑞昔布钠冻干制剂及其制备方法 | |
DE112016001715T5 (de) | Stabile flüssige pharmazeutische Zusammensetzungen von Bortezomib | |
CN106389353A (zh) | 一种注射用复方甘草酸单铵s及其制备方法 | |
CN101664384A (zh) | N-乙酰半胱氨酸盐木糖醇注射液及其制备方法和应用 | |
CN106959347B (zh) | 环磷腺苷葡胺注射液药物组合物的质控方法 | |
CN111643451B (zh) | 一种注射用和厚朴酚自乳化微乳制剂及其制备方法 | |
CN103214382B (zh) | 一种盐酸甲氯芬酯化合物及其药物组合物 | |
CN102240393A (zh) | 一种含有阿加曲班的注射用制剂 | |
CN107019675B (zh) | 注射用环磷腺苷冻干粉针剂药物组合物及质控方法和制法 | |
US10456362B2 (en) | Stabilized pharmaceutical composition and method for preparing same | |
CN111514147B (zh) | 用于急性失代偿心力衰竭症状的左西孟旦钠药用组合物及制备方法 | |
JP3917820B2 (ja) | オザグレルナトリウム含有注射液およびその安定化方法 | |
CN101491495B (zh) | 丹酚酸b镁注射剂、制备方法及应用 | |
CN101313910B (zh) | 一种磷酸肌酸钠冻干粉针剂的制备工艺 | |
CN104069074A (zh) | 一种注射用奥拉西坦及其制备方法 | |
CN101703466A (zh) | 冰片注射剂及其制剂方法 | |
CN114668716A (zh) | 一种新的间苯三酚注射液制备方法 | |
CN102008461B (zh) | 一种注射用布洛芬药物组合物 | |
CN108289897B (zh) | 一种瑞马唑仑的药物组合物 | |
CN101756895B (zh) | 一种多烯磷脂酰胆碱静脉制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: NANJING SIMCERE DOYEA PHARMACEUTICAL CO.,LTD. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20100412 Address after: 210042 Xuanwu Avenue, Jiangsu, Nanjing, No. 699 -18 Applicant after: Jiangsu Simcere Pharmaceutical Research Company Limited Applicant after: Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd. Address before: 210042 Xuanwu Avenue, Jiangsu, Nanjing, No. 699 -18 Applicant before: Jiangsu Simcere Pharmaceutical Research Company Limited |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160804 Address after: 210042 Xuanwu District, Xuanwu District, Jiangsu, Nanjing No. 699 -18 Patentee after: Jiangsu Simcere Pharmaceutical Co., Ltd. Patentee after: Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd. Address before: 210042 Xuanwu Avenue, Jiangsu, Nanjing, No. 699 -18 Patentee before: Jiangsu Simcere Pharmaceutical Research Company Limited Patentee before: Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 210042 -18, Xuanwu Avenue, Xuanwu District, Jiangsu, Nanjing, 699 Patentee after: JIANGSU SIMCERE PHARMACEUTICAL Co.,Ltd. Patentee after: SIMCERE PHARMACEUTICAL Group Address before: 210042, -18, Xuanwu Avenue, Xuanwu District, Jiangsu, Nanjing, Nanjing 699 Patentee before: JIANGSU SIMCERE PHARMACEUTICAL Co.,Ltd. Patentee before: NANJING SIMCERE DONGYUAN PHARMACEUTICA Co.,Ltd. |